Abstract:Context Gastric bypass (GBP) and sleeve gastrectomy (SG) are both effective bariatric treatments that cause sustained weight loss as well as improvement of type 2 diabetes mellitus (T2DM). The underlying mechanisms are under investigation, including the contribution of alterations in bile acids (BAs) in achieving or maintaining the beneficial metabolic effects after bariatric surgery. Aims The aim of this study is to investigate the acute and short-term effects of GBP and SG on BA compositions and fibroblast growth factor 19 (FGF19) in obese individuals with T2DM and to evaluate any correlations between changes in these measures with glucose metabolic improvements. Methods The levels of both fasting and postprandial plasma BA compositions after oral glucose tolerance test (OGTT), fasting FGF19 and various metabolic indices were measured 1 day before and at 3 days and 3 months after GBP and SG in 19 obese patients (GBP = 8, SG = 11) with T2DM. Results Body weight loss was observed after both GBP and SG 3 months post-operatively, with no significant difference between the two intervention groups (15.0 ± 3.1% vs. 13.9 ± 5.2%, P = 0.761). At 3 days post-operation, FGF19 levels increased significantly in both surgery groups (GBP, 118.3 ± 57.3 vs. 363.6 ± 131.0 pg mL −1 , post-operation P = 0.008; SG, 173.2 ± 127.8 vs. 422.0 ± 243.6 pg mL −1 , post-operation P = 0.001). Fasting and postprandial increases from pre-operative values in secondary ( r = 0.57, P = 0.02; r = 0.58, P = 0.01), conjugated ( r = 0.50, P = 0.01; r = 0.48, P = 0.04), glycine-conjugated ( r = 0.52, P = 0.05; r = 0.46, P = 0.05) and secondary-conjugated ( r = 0.53, P = 0.02; r = 0.60, P = 0.01) BAs correlated with decreases in the postprandial states of glucose (defined by area under the curve (AUC) over 120 min (AUC 0-120min )). Increases in postprandial primary-conjugated BAs were found to be associated with decreases in HOMA-IR ( r = 0.45, P = 0.05). However, increases in fasting and postprandial taurine-conjugated BA correlated with decreases in both basal insulin secretion rate ( r = 0.47, P = 0.04; r = 0.48, P = 0.04) and C-peptide level ( r = 0.45, P = 0.05; r = 0.47, P = 0.04). After 3 months, fasting and postprandial increases in secondary ( r = 0.51, P = 0.03; r = 0.48, P = 0.04), secondary-conjugated ( r = 0.52, P = 0.02; r = 0.51, P = 0.03) and non-12α-OH ( r = 0.51, P = 0.02; r = 0.58, P = 0.01) BAs were found to correlate with increases in Stumvoll Insulin Sensitivity Index. Increases in both fasting and postprandial 12α-OH BAs were correlated with the decreases in glucose AUC ( r = 0.46, P = 0.05; r = 0.41, P = 0.04). Conclusions Both GBP and SG achieve increases in many BA species as early as 3 days post-operation, which are sustained at 3 months post-operation. Rises in secondary BA and conjugated forms are correlated with early improvements in glucose metabolism at 3 days post-operation. These along with 12α-OH BA correlated with improved glucose metabolism at 3 months post-operation, suggesting they may contribute to the observed T2DM remission after bariatric surgery.

Increase in bile acids after sleeve gastrectomy improves metabolism by activating GPBAR1 to increase cAMP in mice with nonalcoholic fatty liver disease

Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality

Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy

Bile Acid Composition Contributes to Metabolic Improvements after Sleeve Gastrectomy in Mice

Sleeve Gastrectomy Ameliorated High-Fat Diet (Hfd)-Induced Non-Alcoholic Fatty Liver Disease and Upregulated the Nicotinamide Adenine Dinucleotide +/ Sirtuin-1 Pathway in Mice.

Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass

Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery

The Role of Bile Acid in Improving Glucose Tolerance of Non-Obese Diabetic Rats after Proximal Small Bowel Bypass

Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice

Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity

Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy

Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice

A small intestinal bile acid modulates the gut microbiome to improve host metabolic phenotypes following bariatric surgery

Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice

Changes in fasting bile acid profiles after Roux-en-Y gastric bypass and sleeve gastrectomy

Effects of Sleeve Gastrectomy on Lipid and Energy Metabolism in ZDF Rats Via PI3K/AKT Pathway.

Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery

Type 2 Diabetes Mitigation in the Diabetic Goto–Kakizaki Rat by Elevated Bile Acids Following a Common-Bile-duct Surgery

Effects of Bile Acid Modulation by Dietary Fat, Cholecystectomy, and Bile Acid Sequestrant on Energy, Glucose, and Lipid Metabolism and Gut Microbiota in Mice

Bile Acid, Glucose, Lipid Profile, and Liver Enzyme Changes in Prediabetic Patients 1 Year after Sleeve Gastrectomy

CYP8B1 Downregulation Mediates the Metabolic Effects of Vertical Sleeve Gastrectomy in Mice.